Myotonic dystrophy

disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes

Kevin Yum, Eric T. Wang, Auinash Kalsotra

Research output: Contribution to journalReview article

Abstract

Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease primarily characterized by myotonia and progressive muscle weakness. The pathogenesis of DM involves microsatellite expansions in noncoding regions of transcripts that result in toxic RNA gain-of-function. Each successive generation of DM families carries larger repeat expansions, leading to an earlier age of onset with increasing disease severity. At present, diagnosis of DM is challenging and requires special genetic testing to account for somatic mosaicism and meiotic instability. While progress in genetic testing has been made, more rapid, accurate, and cost-effective approaches for measuring repeat lengths are needed to establish clear correlations between repeat size and disease phenotypes.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalCurrent Opinion in Genetics and Development
Volume44
DOIs
StatePublished - Jun 1 2017

Fingerprint

Myotonic Dystrophy
Penetrance
Genetic Testing
Age of Onset
Myotonia
Phenotype
Neuromuscular Diseases
Mosaicism
Poisons
Muscle Weakness
Microsatellite Repeats
RNA
Costs and Cost Analysis

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Myotonic dystrophy : disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. / Yum, Kevin; Wang, Eric T.; Kalsotra, Auinash.

In: Current Opinion in Genetics and Development, Vol. 44, 01.06.2017, p. 30-37.

Research output: Contribution to journalReview article

@article{27a63e0e4d2d4d198d0290d004577c93,
title = "Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes",
abstract = "Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease primarily characterized by myotonia and progressive muscle weakness. The pathogenesis of DM involves microsatellite expansions in noncoding regions of transcripts that result in toxic RNA gain-of-function. Each successive generation of DM families carries larger repeat expansions, leading to an earlier age of onset with increasing disease severity. At present, diagnosis of DM is challenging and requires special genetic testing to account for somatic mosaicism and meiotic instability. While progress in genetic testing has been made, more rapid, accurate, and cost-effective approaches for measuring repeat lengths are needed to establish clear correlations between repeat size and disease phenotypes.",
author = "Kevin Yum and Wang, {Eric T.} and Auinash Kalsotra",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.gde.2017.01.007",
language = "English (US)",
volume = "44",
pages = "30--37",
journal = "Current Opinion in Genetics and Development",
issn = "0959-437X",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Myotonic dystrophy

T2 - disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes

AU - Yum, Kevin

AU - Wang, Eric T.

AU - Kalsotra, Auinash

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease primarily characterized by myotonia and progressive muscle weakness. The pathogenesis of DM involves microsatellite expansions in noncoding regions of transcripts that result in toxic RNA gain-of-function. Each successive generation of DM families carries larger repeat expansions, leading to an earlier age of onset with increasing disease severity. At present, diagnosis of DM is challenging and requires special genetic testing to account for somatic mosaicism and meiotic instability. While progress in genetic testing has been made, more rapid, accurate, and cost-effective approaches for measuring repeat lengths are needed to establish clear correlations between repeat size and disease phenotypes.

AB - Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease primarily characterized by myotonia and progressive muscle weakness. The pathogenesis of DM involves microsatellite expansions in noncoding regions of transcripts that result in toxic RNA gain-of-function. Each successive generation of DM families carries larger repeat expansions, leading to an earlier age of onset with increasing disease severity. At present, diagnosis of DM is challenging and requires special genetic testing to account for somatic mosaicism and meiotic instability. While progress in genetic testing has been made, more rapid, accurate, and cost-effective approaches for measuring repeat lengths are needed to establish clear correlations between repeat size and disease phenotypes.

UR - http://www.scopus.com/inward/record.url?scp=85012247350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012247350&partnerID=8YFLogxK

U2 - 10.1016/j.gde.2017.01.007

DO - 10.1016/j.gde.2017.01.007

M3 - Review article

VL - 44

SP - 30

EP - 37

JO - Current Opinion in Genetics and Development

JF - Current Opinion in Genetics and Development

SN - 0959-437X

ER -